| Literature DB >> 34158074 |
Molly Tillmann1, Qian Tang2, Jerry D Cohen2.
Abstract
Entities:
Keywords: Auxin biosynthesis; LC–MS; Metabolic inhibitors; Pathway analysis; Stable isotope labeling
Year: 2021 PMID: 34158074 PMCID: PMC8220744 DOI: 10.1186/s13007-021-00763-0
Source DB: PubMed Journal: Plant Methods ISSN: 1746-4811 Impact factor: 4.993
Fig. 1Major pathways for IAA biosynthesis. Solid arrows refer to pathways with enzymes identified in at least one species, and dashed arrows to undefined ones. AMI1, indole-3-acetamide hydrolase-1; ANT, anthranilate; CHA, chorismic acid; IAAld, indole-3-acetaldehyde; CYP79B2/3, cytochrome P450 (79B2/3); IAM, indole-3-acetamide; IAN, indole-3-acetonitrile; IAOx, indole-3-acetaldoxime; IGP, indole-3-glycerol phosphate; INS, indole synthase; IPyA, indole-3-pyruvic acid; ISS1, Indole Severe Sensitive 1; NIT, nitrilase; Ser, serine; TAA1, tryptophan aminotransferase of Arabidopsis 1; TAR, tryptophan aminotransferase-related; TAM, tryptamine; Trp, tryptophan; TSA, tryptophan synthase α; TSB, tryptophan synthase β; YUCCA, Arabidopsis flavin monooxygenase
Fig. 2Workflow summary for labeling and analysis of the auxin metabolic network. Various labeling and analysis techniques are used to investigate different aspects of auxin biosynthesis. For absolute quantitation, internal standards are added to samples prior to homogenization
Some chemical inhibitors of auxin biosynthesis
| Inhibitor name | Representative structure(s) | Target | Mode of action | Reference |
|---|---|---|---|---|
| BBo | 3-chlorophenylboronic acid, 4-biphenylboronic acid | YUCCA | Competitive inhibitor | [ |
| PPBo | 4-phenoxyphenyl-boronic acid | YUCCA | Competitive inhibitor | [ |
| Ponalrestat | 2-(3-(4-Bromo-2-fluorobenzyl)-4-oxo-3,4-dihydrophthalazin-1-yl)acetic acid | YUCCA | Substrate antagonist | [ |
| Yucasin | 5-(4-chlorophenyl)-4H-1,2,4-triazole-3-thione | YUCCA | Competitive inhibitor | [ |
| Yucasin DF (YDF) | 5-[2,6-difluorophenyl]-2,4-dihydro-[1,2,4]triazole-3-thione | YUCCA | Competitive inhibitor | [ |
| Pyruvamines (PVM) “Type I compounds” | PVM1169; L-alpha-(aminooxy)-3-(naphthalen-2-yl)propanoic acid | TAA1 | Competitive inhibitor | [ |
| Pyruvamines (PVM) “Type II compounds” (Derivatives of Type I compounds) | PVM2153; Benzene propanoic acid, 3,4-dichloro-α-[(1,3-dihydro-1,3-dioxo- 2H-isoindol-2-yl)oxy]-, methyl ester | TAA1 | Competitive inhibitor | [ |
| L-Kynurenine (Kyn) | (2S)-2-Amino-4-(2-aminophenyl)-4-oxobutanoic acid | TAA1 | Alternative substrate/ Competitive inhibitor | [ |
| AVG | Aminoethoxyvinyl-glycine | TAA1 | Slow-binding inhibition | [ |
| AOPP | L-aminooxyphenyl-propionic acid | TAA1 | Competitive inhibitor | [ |
| AOA | Amino-oxyacetic acid | TAA1 | [ | |
| AOIBA | 2-amino-oxyisobutyric acid | TAA1 | [ | |
| Indoleacrylic acid | trans-indole-3-acrylic acid | Trp synthase β and α | Allosteric inhibitor | [ |
| (1-Fluorovinyl)glycine | α-(1′-fluoro)vinyl glycine | Trp synthase β | PLP-enzyme mechanism-based inhibitor | [ |
| Arylsulfide phosphonates | [4-[(2-aminophenyl) sulfanyl]butyl] phosphonic acid | Trp synthase α | Transition state analog | [ |
| Indoline-5-sulfonamides | 1-(2-Fluorobenzoyl)-N-methyl-5-indoline sulfonamide N-Methyl-1-[(5-methyl-2-thienyl)carbonyl]-5-indolinesulfonamide | Trp synthase inter- subunit interface | Allosteric inhibitor | [ |
| Sulfolane and indole-5-sulfonamide | GSK1, (3R,4R)-4-[4-(2-chlorophenyl)piperazin-1-yl]-1,1-dioxothiolan- 3-ol); GSK2, (1-[2-fluorobenzoyl]-N-methyl-2,- 3-dihydro-1H-indole-5-sulfonamide) | Trp synthase inter- subunit interface | Allosteric inhibitor | [ |
| Aryl sulfonamides | [F9]; N-(4’-Trifluoromethoxy benzenesulfonyl)-2-aminoethyl Phosphate | Trp synthase β | α-Site allosteric ligand | [ |
| Benzamide | N-(4-Carbamoyl benzyl)-5-(3-chloro phenyl)-1,2-oxazole-3-carboxamide | Trp synthase α | α-Site ligand | [ |
Labeling precursors used for different applications. Example labeling strategies employing different stable isotope-labeled precursors for studying IAA biosynthesis. These strategies can be used in combination with various inhibitors (Table 1) for targeted analysis of specific routes of IAA biosynthesis
| Labeled precursor treatment | Germination Media | Purpose/Description |
|---|---|---|
| 3 mM [13C3]Serine | [14 N] ATS | Traces synthesis of Trp and Trp-dependent pathway intermediates. [13C3]Serine is condensed with indole to give [13C3]Trp ([13C3]-label is incorporated into Trp sidechain) |
| 500 μM [13C6]anthranilate and 500 μM [15N1]indole | [14 N] ATS | Multiple auxin precursors upstream of Trp are applied to monitor label incorporation into various intermediates through multiple pathways |
| 500 μM [13C815N1]indole and 500 μM [15N1]indole | [14 N] ATS | Multiple labeled forms of indole are applied to label indole-derived metabolites and potential IAA biosynthesis intermediates. LC–MS/MS analysis workflow for identifying candidate compounds is described in the Materials LC–MS analysis section |
| 500 μM [13C6]anthranilate and 500 μM [13C815N1]indole | [15 N] ATS | Growing seedlings on [15 N] ATS media enables rapid [15 N]-labeling of newly synthesized IAA and biosynthesis intermediates during early seedling development (Fig. Unlabeled internal standards may be used for quantitation of IAA and biosynthetic intermediates in plant tissue grown on [15 N] ATS (reverse isotope dilution quantitation) |
Fig. 3Representative results from analysis of Trp, IPyA, and IAA extracted from Arabidopsis seedlings. 13-day-old seedlings grown on 15 N media were subjected to mock inhibitor treatment (DMSO + ACN) for 22 h, then labeled with 500 μM [13C8, 15N1] indole for 1 h. [15N2]Trp, [13C8, 15N1]Trp, [15N1]IPyAox, and [13C8, 15N1]IPyAox were monitored in SIM mode. [15N1] IAA [15N1]quinolinium and [13C8, 15N1]IAA [13C8, 15N1]quinolinium transitions were monitored in PRM mode
The m/z values of isotopomers measured in the IAA and intermediates analyses
| M(+H) | 15N1 | 13C1 | 15N2 | 13C115N1 | 13C115N2 | |
|---|---|---|---|---|---|---|
| ANT | 138.0550 | 139.0520 | 139.0583 | 140.0553 | ||
| IND | 118.0651 | 119.0622 | 119.0685 | 120.0655 | ||
| Trp | 205.0972 | 206.0942 | 206.1005 | 207.0912 | ||
| Ser | 106.0499 | 107.0469 | 107.0532 | |||
| TAM | 161.1073 | 162.1044 | 162.1107 | 163.1014 | 163.1077 | 164.1047 |
| IAOx | 175.0866 | 176.0836 | 176.0899 | 177.0807 | 177.0870 | 178.0840 |
| IAM | 175.0866 | 176.0836 | 176.0899 | 177.0807 | 177.0870 | 178.0840 |
| IAN | 157.0760 | 158.0731 | 158.0794 | 159.0701 | 160.0734 | |
| IPyAox | 233.0921 | 234.0891 | 234.0954 | 235.0925 | ||
| IAAldox | 189.1022 | 190.0993 | 190.1056 | 191.1026 | ||
| IAA | 176.0706 | 177.0676 | 177.0740 | 178.0710 | ||
| Quinolinium | 130.0651 | 131.0622 | 131.0685 |
Common problems and troubleshooting guide.
Adapted from Liu et al. [26]
| Problem | Possible reasons | Solutions |
|---|---|---|
| Liquid does not pass through TopTips before loading plant samples | The slit on TopTips is too narrow | Increase the centrifugal force to make liquid pass through, or switch to a new TopTip |
| Liquid does not pass through TopTips after loading plant samples | Plant debris blocks the TopTip slit | Always try to avoid transferring plant debris into TopTips Increase the centrifugal force to make liquid pass through Use a dissecting probe to remove visible plant debris |
| Drift of LC retention time | Injection volume is too large | Evaporate eluate or extract to a smaller volume with vacuum concentrator Reduce the sample volume injected onto the LC |
| Change of LC mobile phase | Check that correct, freshly prepared mobile phase solvents are being used Purge the LC lines after changing solvents | |
| LC solvents are blocked or leaking | Replace the precolumn filter Check column connections and reinstall if needed Check LC lines for leaking solvent | |
| Low yield of labeled compounds, but normal yield of endogenous compounds and/or internal standards | Slow turnover | Increase the labeling time period |
| Insufficient intake of labeled precursors | Increase the concentration of labeled precursors in the labeling solution Make sure plants are bathed in sufficient volume of labeling solution | |
| Broad/tailed LC peaks | Injection volume is too large | Evaporate eluate or extract to a lower volume with vacuum concentrator Reduce the sample volume injected onto the LC |
| The precolumn filter is dirty | Replace the filter | |
| The column is dirty | Disconnect the LC line from the MS source and wash the column with solvent according to manufacturer’s instructions | |
| Analyte | The MS needs to be calibrated | Perform mass calibration with calibration standard mixture according to instrument manual |
| Reduced MS sensitivity | The MS needs to be calibrated | See above |
| The tune file needs to be modified | Adjust source parameters for optimal ion intensity using standard compounds |